CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti ...

Retrieved on: 2025-05-02 18:32:52

Tags for this article:

Click the tags to see associated articles and topics

CD56 expression modulates NAD+ metabolic landscape and predicts sensitivity to anti .... View article details on hiswai:

Excerpt

In multiple myeloma (MM), monoclonal antibodies targeting CD38, such as Daratumumab (Dara) and Isatuximab (Isa), are standard-of-care drugs that ...

Article found on: www.nature.com